A nurse is providing instructions about bowel cleansing with polyethylene glycol-electrolyte solution (PEG) for a client who is going to have a colonoscopy. Which of the following information should the nurse include?

A. Requesting an order for an antiemetic may be necessary if the client continues to experience nausea, but it is not the first action the nurse should take. Before administering medication, the nurse should assess the client's vital signs and overall condition to determine the appropriate intervention.
B. While a dietitian consult may be beneficial to address the client's nutritional needs, it is not the first action the nurse should take in response to the client's symptoms of nausea and weakness. Assessing the client's vital signs and condition should be the priority.
C. Suggesting that the client rests before eating the meal may be helpful, but it does not address the underlying cause of the client's symptoms. The nurse should first assess the client's vital signs to determine the severity of the symptoms and any potential complications.
D. Checking the client's vital signs is the first action the nurse should take in response to the client's symptoms of nausea and weakness. Vital signs, including blood pressure, heart rate, respiratory rate, and temperature, can provide valuable information about the client's hemodynamic status and help identify any potential complications, such as dehydration or worsening heart failure. Based on the vital signs assessment, the nurse can then implement appropriate interventions, such as notifying the healthcare provider or providing symptomatic relief.

A. Fresh frozen plasma: Fresh frozen plasma contains clotting factors, including factor VIII, but it is not the primary treatment for hemophilia A. While it can be used in emergency situations to temporarily increase clotting factor levels, it is not typically administered prophylactically before dental procedures.
B. Recombinant factor VIII: This is the correct answer. Recombinant factor VIII is the treatment of choice for individuals with hemophilia A. It is administered to replace the deficient factor VIII in the blood, thereby promoting clot formation and preventing excessive bleeding during surgical procedures such as wisdom teeth extractions.
C. Packed red blood cells (RBCs): Packed red blood cells are not typically indicated for the treatment of hemophilia A. While they may be necessary if significant blood loss occurs during the procedure, the primary treatment is replacement of the deficient clotting factor.
D. Prophylactic antibiotics: Prophylactic antibiotics may be prescribed to prevent infection following dental procedures, especially in individuals with bleeding disorders who are at increased risk of infection due to compromised immune function. However, the primary treatment for hemophilia A prior to dental procedures is replacement therapy with clotting factor concentrates like recombinant factor VIII.